Table 1 Clinical and epidemiological characteristics of CLD patients with and without DM
From: Prevalence and determinants of diabetes mellitus among Iranian patients with chronic liver disease
Diabetic | Non-diabetic | P-value | |
|---|---|---|---|
Number | 40 | 148 | |
Sex | NS | ||
Female | 9 (22.5%) | 26 (17.9%) | |
Male | 31 (77.5%) | 119 (82.1%) | |
Age | 50.3 ± 11.4 | 40.2 ± 10.6 | 0.000 |
CLD status | 0.000 | ||
Inactive carrier | 4 (10.0%) | 38 (26.2%) | |
Chronic hepatitis | 14 (35.0%) | 88 (60.7%) | |
Cirrhosis | 22 (55.0%) | 19 (13.1%) | |
CLD etiology | NS | ||
HBV | 24 (60.0%) | 85 (58.6%) | |
HCV | 13 (32.5%) | 58 (40.0%) | |
Cryptogenic | 3 (7.5%) | 2 (1.4%) | |
Family history of DM* | 0.000 | ||
Yes | 21 (52.5%) | 29 (20.0%) | |
No | 19 (47.5%) | 116 (80%) | |
History of hypertension† | 0.007 | ||
Yes | 10 (25.0%) | 13 (9.0%) | |
No | 30 (75.0%) | 132 (91.0%) | |
BMI | 27.5 ± 4.6 | 24.7 ± 4.0 | 0.009 |
Interferon therapy | NS | ||
Yes | 6 (15.0%) | 49 (33.8%) | |
No | 34 (85.0%) | 96 (66.2%) | |
Smoking | NS | ||
Yes | 13 (32.5%) | 37 (25.5%) | |
No | 27 (67.5%) | 108 (74.5%) | |
TG | 179.2 ± 74.1 | 142.8 ± 71.4 | NS |
Chol | 192.4 ± 39.8 | 174.7 ± 44.4 | NS |